FDA enforcement declines – House report
This article was originally published in The Tan Sheet
Executive Summary
FDA enforcement of food and drug laws declined "dramatically" between 2000 and 2005, and FDA officials "routinely reject the enforcement recommendations of career field staff," according to a report released by the Democratic staff of the House Government Reform Committee June 26. The report was requested by Rep. Henry Waxman (D-Calif.). The number of warning letters sent by the agency for violations decreased in all FDA centers by an average of over 50%, from 1,154 issued in 2000 to 535 in 2005, the report states. Warning letters for the Center for Food Safety & Applied Nutrition declined 45%. Additionally, the number of products seized by the agency for being defective, mislabeled or dangerous dropped 44%, the study finds. The decrease in enforcement actions does not indicate a reduction in violations; the number of violations reported by FDA field agents has remained relatively constant, the report maintains. Waxman, CSPI and Public Citizen held a joint news conference on FDA's "failings" June 27....
You may also be interested in...
Fewer Warning Letters: Does Change Point To FDA Advancement Or Decline?
A growing preference for voluntary compliance from drug firms is one contributor to the "steady decrease in the number of CDER warning letters," according to FDAer Robert Maffei
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.